Wordt geladen...
Potential biomarkers of ductal carcinoma in situ progression
BACKGROUND: Ductal carcinoma in situ is a non-obligate precursor of invasive breast carcinoma and presents a potential risk of over or undertreatment. Finding molecular biomarkers of disease progression could allow for more adequate patient treatment. We aimed to identify potential biomarkers that c...
Bewaard in:
| Gepubliceerd in: | BMC Cancer |
|---|---|
| Hoofdauteurs: | , , , , , , , , , , , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
BioMed Central
2020
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7017577/ https://ncbi.nlm.nih.gov/pubmed/32050925 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-020-6608-y |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|